Stonewise Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
Stonewise General Information
Description
Manufacturer of an artificial intelligence drug discovery system designed to accelerate and improve the early stages of pharmaceutical development. The company offers integrated AI-driven capabilities such as pocket finding, molecular generation, ultra-high throughput virtual screening, rational design, and druggability optimisation, enabling pharmaceutical researchers and biopharmaceutical companies to advance from hit identification to preclinical candidate optimisation with greater speed and efficiency.
Contact Information
Website
www.stonewise.aiCorporate Office
- 10th Floor, Block A, Sinosteel Plaza
- Number 8 Haidian Street, Haidian District, Beijing
- Beijing, 100080
- China
Corporate Office
- 10th Floor, Block A, Sinosteel Plaza
- Number 8 Haidian Street, Haidian District, Beijing
- Beijing, 100080
- China
Stonewise Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 01-Jan-2026 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B1) | 12-Apr-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 09-Sep-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 16-Mar-2020 | $10M | $10M | Completed | Generating Revenue | |
| 1. Seed Round | 23-Jul-2019 | Completed | Startup |
Stonewise Comparisons
Industry
Financing
Details
Stonewise Competitors (1)
One of Stonewise’s competitors is Numerion Labs, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Numerion Labs | Venture Capital-Backed | San Francisco, CA |
Stonewise Patents
Stonewise Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026061487-A1 | Molecular prediction model training method and protein pocket processing method | Pending | 20-Sep-2024 | ||
| WO-2023226679-A1 | 3c-like protease inhibitor | Inactive | 27-May-2022 | ||
| WO-2023227117-A1 | 3c-like protease inhibitor | Inactive | 27-May-2022 | ||
| WO-2023227118-A1 | 3c-like protease inhibitor | Inactive | 27-May-2022 |
Stonewise Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Soul Capital (China) | Venture Capital | Minority | ||
| Xiang He Capital | Venture Capital | Minority | ||
| CDH Investments | PE/Buyout | Minority | ||
| Eastern Bell Venture Capital | Venture Capital | Minority | ||
| Greater Bay Area Homeland | Venture Capital | Minority |
Stonewise FAQs
-
When was Stonewise founded?
Stonewise was founded in 2018.
-
Where is Stonewise headquartered?
Stonewise is headquartered in Beijing, China.
-
What industry is Stonewise in?
Stonewise’s primary industry is Drug Discovery.
-
Is Stonewise a private or public company?
Stonewise is a Private company.
-
What is Stonewise’s current revenue?
The current revenue for Stonewise is .
-
How much funding has Stonewise raised over time?
Stonewise has raised $50M.
-
Who are Stonewise’s investors?
Soul Capital (China), Xiang He Capital, CDH Investments, Eastern Bell Venture Capital, and Greater Bay Area Homeland are 5 of 11 investors who have invested in Stonewise.
-
Who are Stonewise’s competitors?
Numerion Labs is a competitor of Stonewise.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process